Enhanced and/or standardized ability to measure and quantitatively evaluate the glycan profile of a reference monoclonal antibody.
The University of Massachusetts will procure a Waters BioAccord LC-MS system. This approach will be used to measure and quantitatively evaluate the glycan profile of a reference monoclonal antibody using glycan standards as well as the glycan profile of a reference monoclonal antibody where the release was performed at a central laboratory.
Upon project completion, the Waters BioAccord LC-MS system will be available on a priority basis for NIIMBL-related technology and workforce activities, within any necessary constraints of the host institution, to be negotiated with NIIMBL.
Evaluate whether “community performance metrics” can be defined for NISTmAb released and/or released/labeled methods
Evaluate modes of implementation of a new quantitative glycan standard, SRM 3655
Understand if SRM 3655 can assist in harmonizing or standardizing glycan measurements
Login to the NIIMBL member portal to access additional project information, including presentations, progress updates, reports, and more.
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.
University of Massachusetts System
